Your browser doesn't support javascript.
loading
Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, double-blind, multinational, phase 3 study.
Saad, Fred; Efstathiou, Eleni; Attard, Gerhardt; Flaig, Thomas W; Franke, Fabio; Goodman, Oscar B; Oudard, Stéphane; Steuber, Thomas; Suzuki, Hiroyoshi; Wu, Daphne; Yeruva, Kesav; De Porre, Peter; Brookman-May, Sabine; Li, Susan; Li, Jinhui; Thomas, Shibu; Bevans, Katherine B; Mundle, Suneel D; McCarthy, Sharon A; Rathkopf, Dana E.
Afiliação
  • Saad F; Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montréal, QC, Canada. Electronic address: fred.saad@umontreal.ca.
  • Efstathiou E; Athens Medical Center, Dept of GU Oncology, Athens, Greece.
  • Attard G; University College London, London, UK.
  • Flaig TW; University of Colorado Cancer Center, Aurora, CO, USA.
  • Franke F; ONCOSITE, Hospital Unimed Noroeste, Ijuí, Brazil.
  • Goodman OB; Comprehensive Cancer Centers of Nevada, US Oncology Network, Las Vegas, NV, USA.
  • Oudard S; Georges Pompidou Hospital, University of Paris, Paris, France.
  • Steuber T; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Suzuki H; Toho University Sakura Medical Center, Chiba, Japan.
  • Wu D; Janssen Research & Development, Los Angeles, CA, USA.
  • Yeruva K; Janssen Research & Development, Los Angeles, CA, USA.
  • De Porre P; Janssen Research & Development, Beerse, Belgium.
  • Brookman-May S; Janssen Research & Development, Los Angeles, CA, USA; Ludwig Maximilians University, Munich, Germany.
  • Li S; Janssen Research & Development, Spring House, PA, USA.
  • Li J; Janssen Research & Development, San Diego, CA, USA.
  • Thomas S; Janssen Research & Development, Spring House, PA, USA.
  • Bevans KB; Janssen Global Services, Horsham, PA, USA.
  • Mundle SD; Janssen Research & Development, Raritan, NJ, USA.
  • McCarthy SA; Janssen Research & Development, Raritan, NJ, USA.
  • Rathkopf DE; Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, NY, USA.
Lancet Oncol ; 22(11): 1541-1559, 2021 11.
Article em En | MEDLINE | ID: mdl-34600602
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tioidantoínas / Prednisona / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Próstata Resistentes à Castração / Acetato de Abiraterona Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tioidantoínas / Prednisona / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Próstata Resistentes à Castração / Acetato de Abiraterona Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article